'We could have done without this': Romain Bardet on how Chris Froome case has damaged cycling

Ag2r La Mondiale leader hopes for quick resolution to case

Rigoberto Uran, Romain Bardet, and Chris Froome cross the line at the end of stage 18 of the Tour de France

(Image credit: ASO/Alex Broadway)

Romain Bardet has said that Chris Froome's adverse analytical finding (AAF) for high levels of salbutamol has damaged the credibility of cycling, and that he hopes for a quick resolution to the case.

Bardet, who finished third behind Froome at the Tour de France in July, said that the news that the Team Sky rider had twice the permitted level of asthma drug salbutamol in his urine after stage 18 of the Vuelta a España had an impact on everyone in the sport.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Henry Robertshaw began his time at Cycling Weekly working with the tech team, writing reviews, buying guides and appearing in videos advising on how to dress for the seasons. He later moved over to the news team, where his work focused on the professional peloton as well as legislation and provision for cycling. He's since moved his career in a new direction, with a role at the Department for Environment, Food and Rural Affairs.